|
Symbol
|
AWSBIL | ZYALTQ | SKS4LK | OVCRCH | OZTRCH | Z0A4JZ | AANOTQ | ABVHSQ | AYSBIL | LXORLK | Z0ATYZ | CQWBKB | ACDQTQ | RMAKRV | RMAG0V | RSTALV | Z0B7EZ | UJERWU | LZPRCH | RMBGJV |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Multi Reverse Convertible | Multi Reverse Convertible | LUKB Softcallable Multi Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Autocallable Reverse Convertible Defensive worst | Multi Reverse Convertible | Multi Reverse Convertible | Reverse Convertible | LUKB Multi Reverse Convertible | Autocallable Reverse Convertible Defensive worst | Reverse Convertible | Multi Reverse Convertible | Autocallable Multi Vonti | Autocallable Multi Vonti | Reverse Convertible | Autocallable Reverse Convertible Defensive worst | GOAL | Worst of Callable Reverse Convertible | Multi Vonti |
|
Basiswert
|
Compagnie Financière Richemont SA / Logitech International SA / Sika AG / Straumann Hldg. AG | Givaudan / Sonova Hldg. AG / Straumann Hldg. AG | Julius Baer Group / Roche AG / Straumann Hldg. AG | Novartis AG / Sandoz Group AG / Straumann Hldg. AG | Kühne & Nagel Intl. AG / Straumann Hldg. AG / VAT Group | ABB / Holcim/Amrize Basket / Straumann Hldg. AG | Adecco Group AG / OC Oerlikon N / Straumann Hldg. AG / VAT Group | Baloise N / Sandoz Group AG / Sika AG / Straumann Hldg. AG | Alcon / Sonova Hldg. AG / Straumann Hldg. AG / Ypsomed Hldg. AG | Givaudan / Julius Baer Group / Straumann Hldg. AG | Alcon / Novartis AG / Sandoz Group AG / Straumann Hldg. AG | Lonza Group N / Novartis N / Roche GS / Straumann Hldg. AG | Adecco Group AG / Logitech International SA / Stadler Rail AG / Straumann Hldg. AG / UBS Group AG | Lonza Group N / Sika AG / Straumann Hldg. AG | Lonza Group N / Sika AG / Straumann Hldg. AG | Straumann Hldg. AG | Alcon / Straumann Hldg. AG / Ypsomed Hldg. AG | Bachem Hldg. AG / Lonza Group N / Straumann Hldg. AG | SGS S.A. Ltd. / Sika AG / Straumann Hldg. AG | Alcon / Lonza Group N / Novartis AG / Straumann Hldg. AG |
|
Emittent
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fälligkeit
|
23.10.2026 | 02.11.2026 | 10.07.2026 | 09.06.2026 | 07.04.2026 | 30.03.2026 | 27.09.2029 | 07.10.2026 | 22.04.2027 | 05.03.2027 | 05.03.2027 | 13.03.2028 | 21.03.2030 | 24.06.2026 | 24.06.2026 | 09.12.2025 | 10.12.2026 | 02.08.2027 | 07.08.2029 | 19.08.2027 |
| Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0,019922 | - | - | - | - |
|
Ausübungs-Preis
|
135.512 | 95.289 | 39.21 | 27.975 | 162.33 | 64.7878 | 18.304 | 90.285 | 90.86 | 2'812.194 | 31.4067 | 200.5388 | 18.6875 | 90.77 | 86.26 | 99.61 | 317.85 | 75.3422 | 62.415 | 51.80 |
|
Maximal- rendite p.a. |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Geld | - | 89.76 | 97.24 | - | 90.78 | - | - | 85.50 | - | - | 86.54 | 95.40 | 85.97 | 86.80 | 90.40 | - | 87.81 | 90.00 | - | 96.60 |
| Brief | - | 90.56 | 97.97 | - | 91.58 | - | - | - | - | - | 87.44 | 96.20 | 86.77 | 87.60 | 91.20 | - | 88.71 | 91.00 | - | 97.40 |